UK Brexit White Paper Would Keep Medtech Regulatory System – And Testing Just Once – Intact
Executive Summary
It looks as if the EU medtech regulatory system could survive intact in the UK, given terms of the UK blueprint for its future relationship with the EU after separation. But a storm of controversy must be navigated first.